Clinical outcome and toxicity evaluation of simultaneous integrated boost pelvic IMRT/VMAT at different dose levels combined with androgen deprivation therapy in prostate cancer patients. [electronic resource]
- OncoTargets and therapy 2017
- 4981-4988 p. digital